急性髓系白血病的靶向治疗药物研发进展.

Targeted therapeutic drugs for acute myeloid leukemia(AML)are showing immense development, thereby laying a solid foundation for the precise treatment of AML patients. The paper reviews four types of targeted drugs that have progressed rapidly for AML treatment(by targeting genes or signaling-pathway alterations, targeting apoptosis-related pathways, targeting cell-surface antigens, and targeting immune-related substances). We look forward to the future development directions of targeted drugs, providing references for hematologists and developers of new drugs for AML. [ABSTRACT FROM AUTHOR]